Business Description
Certara Inc
NAICS : 923120
SIC : 5045
ISIN : US15687V1098
Share Class Description:
CERT: Ordinary SharesTotal Employee Number:
1,576Description
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.5 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | 3.31 | |||||
Interest Coverage | 0.46 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.34 | |||||
Beneish M-Score | -2.86 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.4 | |||||
3-Year EBITDA Growth Rate | 4.6 | |||||
3-Year EPS without NRI Growth Rate | -1.5 | |||||
3-Year FCF Growth Rate | -4.7 | |||||
3-Year Book Growth Rate | -0.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 67.46 | |||||
9-Day RSI | 60.08 | |||||
14-Day RSI | 56.21 | |||||
3-1 Month Momentum % | -15.15 | |||||
6-1 Month Momentum % | -41.39 | |||||
12-1 Month Momentum % | -54.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.88 | |||||
Quick Ratio | 1.88 | |||||
Cash Ratio | 1.04 | |||||
Days Sales Outstanding | 72.33 | |||||
Days Payable | 9.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 10.21 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 61.59 | |||||
Operating Margin % | 2.17 | |||||
Net Margin % | -3.6 | |||||
EBITDA Margin % | 21.59 | |||||
FCF Margin % | 15.03 | |||||
OCF Margin % | 21.6 | |||||
ROE % | -1.42 | |||||
ROA % | -0.98 | |||||
ROIC % | 0.66 | |||||
ROC (Joel Greenblatt) % | 105.88 | |||||
ROCE % | 1.07 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 15.25 | |||||
PE Ratio without NRI | 14.97 | |||||
Price-to-Owner-Earnings | 26.89 | |||||
PEG Ratio | 0.68 | |||||
PS Ratio | 2.26 | |||||
PB Ratio | 0.88 | |||||
Price-to-Free-Cash-Flow | 14.78 | |||||
Price-to-Operating-Cash-Flow | 10.35 | |||||
EV-to-EBIT | 70.6 | |||||
EV-to-Forward-EBIT | 9.38 | |||||
EV-to-EBITDA | 11.69 | |||||
EV-to-Forward-EBITDA | 8.1 | |||||
EV-to-Revenue | 2.52 | |||||
EV-to-Forward-Revenue | 2.65 | |||||
EV-to-FCF | 16.79 | |||||
Price-to-GF-Value | 0.43 | |||||
Price-to-Projected-FCF | 0.62 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.59 | |||||
Earnings Yield (Greenblatt) % | 1.42 | |||||
FCF Yield % | 6.95 | |||||
Forward Rate of Return (Yacktman) % | 27.3 |
Certara Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Certara Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 17:00 | In 133 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 132 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 17:00 | In 41 days | ||
| Second quarter earnings results for 2026 | 2026-08-06 | In 40 days | ||
| Jefferies Global Healthcare Conference | 2026-06-03 13:20 | 5.62 (-6.95%) | ||
| William Blair\'s 46th Annual Growth Stock Conference | 2026-06-02 | 6.12 (+5.34%) | ||
| RBC CM Global Healthcare ConferenceDate | 2026-05-19 09:30 | 4.56 (+1.79%) | ||
| General meeting for 2026 | 2026-05-14 09:00 | 4.79 (-5.15%) | ||
| First quarter earnings conference call for 2026 | 2026-05-11 08:30 | 6.31 (+0.32%) | ||
| First quarter earnings results for 2026 | 2026-05-11 | 6.31 (+0.32%) |
Show
Entries
Guru Commentaries on NAS:CERT
No articles.
Press Release
Articles on Certara Inc
No articles.
Headlines
See More- 1
Jun 17, 2026
Certara names Faiz Mohammed interim CFO as John Gallagher steps down
Seeking Alpha • 3:51pm
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers